Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors

Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors

US Patent 9809590 · Granted Nov 7, 2017

Estimated economic value: $14,586,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HER2 mutation inhibitors2025
Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators2025
Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators2025
Compounds for FGFR inhibition2025
Antiviral pyrazolopiridinone compounds2025
Compositions and methods for inhibiting CD732025
KV7 channel activators compositions and methods of use2025
KV7 channel activators compositions and methods of use2025
PI3K inhibitors2025
Protein tyrosine phosphatase inhibitors2025
Protein tyrosine phosphatase inhibitors2025
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I r2024